139 related articles for article (PubMed ID: 25044355)
1. Weight gain after orthotopic liver transplantation: is nonalcoholic fatty liver disease cirrhosis a risk factor for greater weight gain?
Kouz J; Vincent C; Leong A; Dorais M; Räkel A
Liver Transpl; 2014 Oct; 20(10):1266-74. PubMed ID: 25044355
[TBL] [Abstract][Full Text] [Related]
2. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
[TBL] [Abstract][Full Text] [Related]
3. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
[TBL] [Abstract][Full Text] [Related]
4. De novo nonalcoholic fatty liver disease after liver transplantation.
Seo S; Maganti K; Khehra M; Ramsamooj R; Tsodikov A; Bowlus C; McVicar J; Zern M; Torok N
Liver Transpl; 2007 Jun; 13(6):844-7. PubMed ID: 17029282
[TBL] [Abstract][Full Text] [Related]
5. [Effect of body weight mass and its change on the incidence of nonalcoholic fatty liver disease].
Fan JG; Zhou Q; Wo QH
Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):676-9. PubMed ID: 20943079
[TBL] [Abstract][Full Text] [Related]
6. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis.
Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J
Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical associations of posttransplant fatty liver disease.
Lim LG; Cheng CL; Wee A; Lim SG; Lee YM; Sutedja DS; Da Costa M; Prabhakaran K; Wai CT
Liver Int; 2007 Feb; 27(1):76-80. PubMed ID: 17241384
[TBL] [Abstract][Full Text] [Related]
8. Accelerated infant weight gain and risk for nonalcoholic fatty liver disease in early adulthood.
Breij LM; Kerkhof GF; Hokken-Koelega AC
J Clin Endocrinol Metab; 2014 Apr; 99(4):1189-95. PubMed ID: 24423333
[TBL] [Abstract][Full Text] [Related]
9. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
[TBL] [Abstract][Full Text] [Related]
10. Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.
Kimura T; Deshpande GA; Urayama KY; Masuda K; Fukui T; Matsuyama Y
J Gastroenterol Hepatol; 2015 May; 30(5):909-17. PubMed ID: 25469977
[TBL] [Abstract][Full Text] [Related]
11. Sex differences between parental pregnancy characteristics and nonalcoholic fatty liver disease in adolescents.
Ayonrinde OT; Adams LA; Mori TA; Beilin LJ; de Klerk N; Pennell CE; White S; Olynyk JK
Hepatology; 2018 Jan; 67(1):108-122. PubMed ID: 28665032
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
13. Impact of body mass index in liver transplantation for nonalcoholic fatty liver disease and alcoholic liver disease.
O'Neill S; Napetti S; Cornateanu S; Sutherland AI; Wigmore S; Oniscu GC; Adair A
HPB (Oxford); 2017 Dec; 19(12):1074-1081. PubMed ID: 28888774
[TBL] [Abstract][Full Text] [Related]
14. De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation.
Kappus M; Abdelmalek M
Clin Liver Dis; 2017 May; 21(2):321-335. PubMed ID: 28364816
[TBL] [Abstract][Full Text] [Related]
15. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
[TBL] [Abstract][Full Text] [Related]
17. Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.
Malik SM; Devera ME; Fontes P; Shaikh O; Sasatomi E; Ahmad J
Liver Transpl; 2009 Dec; 15(12):1843-51. PubMed ID: 19938117
[TBL] [Abstract][Full Text] [Related]
18. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study.
Caiazzo R; Lassailly G; Leteurtre E; Baud G; Verkindt H; Raverdy V; Buob D; Pigeyre M; Mathurin P; Pattou F
Ann Surg; 2014 Nov; 260(5):893-8; discussion 898-9. PubMed ID: 25379859
[TBL] [Abstract][Full Text] [Related]
19. Weight gain and obesity after liver transplantation.
Richards J; Gunson B; Johnson J; Neuberger J
Transpl Int; 2005 Apr; 18(4):461-6. PubMed ID: 15773968
[TBL] [Abstract][Full Text] [Related]
20. Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies.
Loomis AK; Kabadi S; Preiss D; Hyde C; Bonato V; St Louis M; Desai J; Gill JM; Welsh P; Waterworth D; Sattar N
J Clin Endocrinol Metab; 2016 Mar; 101(3):945-52. PubMed ID: 26672639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
